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VOLUME 18 NUMBER 5 MAY 2017 nature immunology A r t i c l e s and AICE2 (GAAATGASTCA) 14, 15, 17 . BATF and IRF4 are both induced within 4 h of TCR stimulation and thus might initiate the expression of many genes encoding products associated with activation and differentiation 23 .
The role of BATF in T H 2 differentiation has remained unclear due to differing results 13, 24, 25 . BATF was shown not to be required for the development of T H 2 cells 13, 21, 25 , but other studies have reported impaired T H 2 development in distinct Batf −/− mice 24 . Batf3 expression compensates for loss of BATF in T H 2 development, maintaining the expression of IL-4 and IL-10 but not of CTLA-4, and Batf −/− Batf3 −/− (Batf1-Batf3 DKO) T cells lack expression of IL-4, IL-10 and CTLA-4 (ref. 13) . This suggests that genes that are targets of BATFs include some that are sensitive to compensation by endogenous BATF3, but that varying conditions of activation 24 might influence the amount BATF3 or the sensitivity of target genes to compensation by BATF3. In either case, the basis for such differential sensitivity has remained unclear.
Here, we first documented clearly distinct sensitivities of several genes to compensation by BATF3 in Batf −/− T H 2 cells. We found that enhancers that controlled BATF-dependent TCR-inducible genes responded to different levels of BATF-IRF4. For genes that were highly sensitive to low levels of total BATF, endogenous BATF3 was able to compensate for BATF in Batf −/− T H 2 cells, while for genes whose expression required higher levels of BATF, it was unable to do so. By ChIP followed by deep sequencing (ChIP-seq) and ChIP-exo analysis, we found that the sensitivity of enhancers in these genes to BATF was regulated by sequences surrounding AICE motifs that influenced affinity for the BATF-IRF4 ternary complex. ChIP-exo analysis helped to identify a previously unknown AICE2 motif that conferred high affinity for BATF-IRF4 that might control a SNP in the CTLA4 locus known to result in a lower incidence of autoimmune diseases 26, 27 .
RESULTS

GATA-3 and CTLA-4 respond to distinct signal strengths
We assessed the expression of BATF, IRF4, GATA-3 and CTLA-4 in T H 2 cells activated with a 'graded' level of TCR signaling. IRF4 was induced in a gradual and uniform manner in proportion to TCR signal strength (Fig. 1a) , consistent with published reports [8] [9] [10] . BATF expression was also graded and had dose-dependent responses to TCR signaling similar to those of IRF4 ( Fig. 1a) . Gata3 and Ctla4 are known targets of IRF4 and BATF 13, 14, 28 but GATA-3 and CTLA-4 were induced at different strengths of TCR signaling (Fig. 1b) . GATA-3 was induced at low signal strength, while CTLA-4 was induced at higher signal strength (Fig. 1c) . During secondary stimulation, similar graded expression in response to TCR stimulation was observed for BATF and IRF4: GATA-3 expression remained high even at low TCR signal strength during secondary stimulation but was more sensitive to TCR signal strength than was CTLA-4 ( Supplementary  Fig. 1a-c) . Likewise, BATF expression was induced in a graded manner in proportion to peptide dose, with induction of GATA-3 occurring at a low peptide dose and induction of CTLA-4 occurring only at a higher peptide dose ( Supplementary Fig. 1d-f) .
The kinetics of gene expression showed patterns similar to those of the response to TCR dose. BATF and IRF4 were induced on day 1 and accumulated over the next 3 d (Supplementary Fig. 2a) . In contrast, GATA-3 was expressed at nearly maximal levels on day 2, but CTLA-4 was not fully expressed until day 3, which correlated with high levels of BATF and IRF4 (Supplementary Fig. 2b-f) . Thus, the expression of BATF and IRF4 showed a graded response to both the strength of TCR stimulation and length of activation.
Differential compensation of BATF targets in T H 2 cells by Batf3
Expression of CTLA-4 in T H 2 cells was partially dependent on BATF but was completely lacking in Batf −/− Batf3 −/− (Batf1-Batf3 DKO) T H 2 cells, even at a high dose of antibody to the TCR invariant chain CD3ε (anti-CD3ε) in a secondary stimulation, as reported 13 (Fig. 2a,b) . In contrast, expression of GATA-3 in T H 2 cells was BATF independent and was significantly lower in Batf1-Batf3 DKO T H 2 cells than in wild type or Batf −/− T H 2 cells, similar to the expression of IL-10 ( Fig. 2a,b) . Thus, endogenous BATF3 was able to compensate for BATF for the expression of GATA-3 and IL-10 but not for that of CTLA-4. This suggested that BATF target genes in T H 2 cells could have distinct sensitivities to the combined levels of BATF and BATF3.
BATF-dependent gene induction relies on interactions of IRF4 with several amino acid residues of BATF (His55, Lys63 and Glu77) with side chains that face out from the leucine zipper 13 . Substitution of those three BATF amino acids (H55Q, K63D and E77K (BATF-HKE)) eliminated the transcriptional activity of BATF, including IL-17 expression in T H 17 cells, class-switch recombination in B cells and the development of CD24 + DCs 13 (Supplementary Fig. 3a-c) . We assessed the ability of BATF-HKE to restore the expression of GATA-3, IL-10 and CTLA-4 in Batf1-Batf3 DKO T H 2 cells. Retroviral expression of Batf or Batf3 in Batf1-Batf3 DKO T H 2 cells fully restored the expression of GATA-3, IL-10 and CTLA-4 to levels similar to those in wild-type T H 2 cells, as expected 13 (Fig. 2c) . In contrast, expression of BATF-HKE in Batf1-Batf3 DKO T H 2 cells induced the expression of GATA-3 and IL-10 to intermediate levels and failed to induce CTLA-4 ( Fig. 2c) . GATA A r t i c l e s A similar pattern of dependence was observed when BATF levels were assessed across a spectrum in a comparison of cells with wild-type, heterozygous and knockout alleles encoding BATFs. The expression of GATA-3 and IL-10 in Batf +/− Batf3 −/− T H 2 cells, which contain one functional Batf allele, was equal to that in Batf +/+ Batf3 −/− T H 2 cells, which contain two Batf alleles ( Fig. 2d) . In contrast, CTLA-4 expression was significantly lower in Batf +/− Batf3 −/− T H 2 cells than in Batf +/+ Batf3 −/− T H 2 cells ( Fig. 2d) . Finally, retroviral expression of Batf in wild-type T H 2 cells shifted the response to TCR dose such that both GATA-3 and CTLA-4 were induced at a lower dose than required for their induction in cells treated with control vector (Fig. 2e) . In summary, these results showed that GATA-3 and IL-10 were highly responsive to BATF, requiring only a small amount of total BATF and responding to the weak BATF-IRF4 interaction provided by BATF-HKE. In contrast, CTLA-4 was less sensitive to BATF, requiring a large amount of total BATF and responding only with the strong BATF-IRF4 interaction provided by wild-type BATF but not that provided by BATF-HKE.
Varying sensitivity of BATF targets to TCR signal strength
We compared global gene expression in wild-type and Batf1-Batf3 DKO T H 2 cells under weak TCR stimulation (10 ng/ml of anti-CD3ε on day 2, or 2 ng/ml of anti-CD3ε on day 4) or under strong TCR stimulation (10 ng/ml of anti-CD3ε on day 4). Batf1-Batf3 DKO T H 2 cells did not express Ifng, Il4 or Il17a at any dose of anti-CD3ε ( Supplementary Fig. 3d ), which indicated that they did not take on a T H 1 or T H 17 phenotype under T H 2 conditions. In the two conditions of weak TCR stimulation, 30 or 68 genes had expression that was at least threefold higher in wild-type cells than in Batf1-Batf3 DKO cells; with strong TCR stimulation, this increased to 207 genes ( Fig. 3a) . Spearman's rank-order correlation of gene expression was greatest for samples of similar strength of TCR stimulation, and there was strong positive correlation between the two weak-TCR-stimulation conditions (Fig. 3b) . These results indicated that distinct sets of genes were induced by low and high levels of TCR stimulation.
We carried out hierarchical clustering of genes based on the change in expression in wild-type T H 2 cells relative to that in Batf1-Batf3 DKO T H 2 cells. Clusters I and II contained genes with large changes in expression in wild-type T H 2 cells relative to that in Batf1-Batf3 DKO T H 2 cells with weak TCR stimulation, while cluster III contained genes that differed in expression only with strong TCR stimulation ( Fig. 3c,d) . Cluster IV contained genes that had higher A r t i c l e s Table 1 ). Within clusters, a spectrum of sensitivity to strength of activation was evident ( Fig. 3d) . In summary, BATF-dependent genes induced in T H 2 cells exhibited a wide range of sensitivity to TCR signal strengths.
Correlation of enhancer occupancy with TCR sensitivity
We performed ChIP-seq analysis of BATF in wild-type T H 2 cells and of IRF4 in wild-type and Batf1-Batf3 DKO T H 2 cells. To mimic low BATF-IRF4 interaction, we did ChIP-seq analysis of IRF4 in Batf1-Batf3 DKO T H 2 cells stably reconstituted with BATF-HKE. Binding peaks for BATF and IRF4 were co-localized and had similar tag counts within selected genes from microarray clusters I and II, such as Maf and Il10, and within selected genes from cluster III, such as Ahr and Vdr (Fig. 4a) . Such co-localization was consistent with the binding of BATF and IRF4 as a complex, as described for ChIP-seq analysis of BATF-IRF4 inT H 17 cells [13] [14] [15] [16] . IRF4 did not bind to those loci in Batf1-Batf3 DKO T H 2 cells, which showed that the binding of IRF4 to DNA was dependent on BATF in T H 2 cells. Some IRF4 peaks were maintained in the presence of BATF-HKE at the Maf and Il10 loci, which suggested that these were high-affinity IRF4-binding sites that did not require a strong BATF-IRF4 interaction. However, no IRF4 peaks were maintained with BATF-HKE in the Ahr and Vdr loci, which suggested that these binding sites were of low affinity and required a strong interaction between the BATF leucine zipper and IRF4. We performed additional ChIP-seq analysis of IRF4 using the same three TCR-stimulation conditions as those used for global gene-expression analysis. We merged all binding peaks for IRF4 observed with any condition of primary stimulation and performed a Spearman's rank correlation analysis for the binding intensity of BATF and IRF4 (tag counts per peak) for all seven ChIP-seq experiments. The binding of BATF and that of IRF4 were highly correlated in wildtype cells (r = 0.77) (Fig. 4b) . The binding intensity of IRF4 was well correlated (r > 0.6) in twice-activated wild-type T H 2 cells and strong TCR-stimulation conditions, and in the two weakly stimulated samples ( Fig. 4b) . However, the binding intensities of IRF4 were more weakly correlated (r < 0.6) for strong and weak TCR stimulation conditions ( Fig. 4b) . When experimental conditions were ordered by decreasing BATF expression, the Spearman's rank correlation coefficients for IRF4 tag counts were highest for samples of similar BATF expression ( Fig. 4b) . Globally, the binding of IRF4 to enhancers correlated with sensitivity to TCR stimulation. With strong TCR stimulation, the IRF4 tag counts of peaks in genes from clusters I and II (within 50 kb upstream or downstream of the transcription start site) were equal to those in genes from cluster III (Fig. 4c) . However, with weak TCR stimulation, IRF4 tag counts of peaks in genes from cluster III were lower than those in genes from clusters I and II (Fig. 4c) , in agreement with gene-specific differences in the binding of IRF4 to Maf and Il10 (clusters I and II) and Ahr and Vdr (cluster III) ( Fig. 4a) . Specifically, IRF4-binding peaks near Maf and Il10 were similar at strong and weak TCR stimulation (Fig. 4d) A r t i c l e s IRF4-binding peaks near Ahr and Vdr were present with strong TCR stimulation but absent with weak TCR stimulation (Fig. 4d) . The T H 2 cell-related genes Il4, Il5, Il13 and Ctla4 were in cluster III and showed binding of IRF4 (by ChIP-seq analysis) consistent with low sensitivity to TCR stimulation (Supplementary Fig. 4 ). These results suggested that genes with enhancers that bound BATF-IRF4 with high affinity were induced at low TCR signal strength and tolerated weaker interactions between BATF and IRF4. In contrast, genes with enhancers that bound BATF-IRF4 with low affinity were induced at higher TCR signal strength and required full, strong interaction between the BATF leucine zipper and IRF4.
To determine whether compensation for BATF by BATF3 occurred through direct binding of BATF3, we performed ChIP-seq analysis of BATF3 and IRF4 in Batf −/− cells using conditions of strong TCR stimulation. BATF3-and IRF4-binding sites in Batf −/− cells coincided with BATF-and IRF4-binding sites in wild-type cells for genes in clusters I-II and cluster III, as well as in T H 2 cell-related genes ( Supplementary  Fig. 4c,d) . Thus, BATF3 was sufficient to allow binding of IRF4 to many sites on genes in clusters I and II and some sites on genes in cluster III in Batf −/− cells, in agreement with compensation for the expression of GATA-3 and IL-10 by BATF3 in Batf −/− T H 2 cells. Some binding peaks for BATF-IRF4 in the Ctla4 locus in wild-type cells were not bound by BATF3 and IRF4 in Batf −/− cells ( Supplementary  Fig. 4d ), which might explain the failure of BATF3 to compensate for BATF in inducing the expression of CTLA-4. In summary, some BATF-dependent genes with enhancers that bound BATF-IRF4 with high affinity were expressed in Batf −/− T H 2 cells because they bound BATF3 even though it had lower expression than BATF.
High-sensitivity AICE motif revealed by ChIP-exo analysis Some IRF4 peaks (for example, an Ahr peak 108 kb upstream of the transcription start site ('-108 kb peak')) were present only with strong TCR stimulation, while others (for example, Ahr −90 kb peak) were also present with weak TCR stimulation (Fig. 4d) . To identify A r t i c l e s sequences that might distinguish high-affinity peaks from lowaffinity peaks, we first classified peaks as being of high, intermediate or low affinity on the basis of the number of conditions of TCR stimulation in which they occurred (Supplementary Fig. 5a ). Genes from clusters I and II contained more high-affinity peaks and fewer low-affinity peaks than did genes from cluster III ( Supplementary  Fig. 5b ). However, de novo motif analysis of IRF4 peaks of all categories identified enrichment for AP-1, AICE1, AICE2 and ETS motifs but found no significant differences between categories in their sequence motifs (Supplementary Fig. 5c ).
We sought to determine whether nucleotides flanking an AICE motif could influence the binding affinity of BATF-IRF4. To assess this, we used four pairs of electrophoretic mobility-shift assay (EMSA) probes with identical AICE sequences but different flanking regions ( Supplementary  Fig. 6a-d) . We generated AICE probes that had identical core AICE sequences from four high-affinity peaks (AICE1, Enpp6 −45 kb and Bcor +65 kb; and AICE2, Prdm1 +14 kb and Ccr4 +8 kb) and from intermediateaffinity or low-affinity peaks (AICE1, Ptchd3 −26 kb and Mzt1 +230 kb; and AICE2, Ctla4 −33 kb and Snrpe +38 kb). These probes differed in the flanking genomic sequences surrounding identical AICE motifs. Probes from all high-affinity peaks produced a strong BATF-IRF4 complex by EMSA, while probes from intermediate-or low-affinity peaks produced a substantially weaker complex (Supplementary Fig. 6e,f) . Thus, the affinity of an AICE motif for BATF-IRF4 was affected by DNA sequences outside the core AICE motif, but de novo motif analysis of ChIP-seq data was unable to resolve the motif further.
Often, more than one AICE motif was found within one IRF4 ChIP-seq peak ( Fig. 5a and Supplementary Fig. 7a,b) . Conceivably, a peak could arise if one AICE were actually a true binding site for BATF-IRF4, with the other(s) being included on the basis of its (their) proximity to that site. To optimize motif analysis to distinguish the sequence requirements of high-affinity AICE motifs versus those of low-affinity AICE motifs, we needed to identify which motif(s) within a peak was (were) functional for binding BATF-IRF4. Thus, we performed ChIP-exo sequencing 29 in wild-type T H 2 cells. As an example, a peak within intron 2 of Rbm47 had two AICE motif sites (Fig. 5a) . However, ChIP-exo revealed that only one site was actually occupied (Fig. 5a-c) . In other peaks, both AICE motifs identified from motif analysis by ChIP-seq were also found to bind by ChIP-exo analysis (Supplementary Fig. 7a-c) .
To determine which predicted motifs bound IRF4 and BATF, by ChIP-exo analysis, we analyzed the mean ChIP-exo tag counts within 50 bp upstream or downstream of all AICE1, AICE2 and ETS motifs predicted by de novo motif analysis or identified as consensus motifs. ETS motif sites within IRF4 peaks did not show enrichment for binding of BATF and IRF4, as assessed by ChIP-exo analysis (Supplementary Fig. 8a,b) ; this suggested that BATF and IRF4 did not bind directly to ETS motifs. However, in AICE1 and AICE2 sites, a position just upstream of the consensus binding motif for IRF (TTTC in AICE1, or GAAA in AICE2) showed significant enrichment for IRF4 ChIP-exo tag counts, and sites upstream of the consensus binding motif for AP-1 (TGASTCA), as well as those upstream of the consensus binding motif for IRF, showed enrichment for BATF ChIPexo tag counts ( Fig. 5d and Supplementary Fig. 8a ). Next, we filtered AICE1 and AICE2 motifs, either predicted by de novo motif analysis or by consensus motifs, to identify sites that had significantly higher ChIP-exo tag counts upstream of IRF4-and BATF-binding sites than on flanking control bases. This analysis defined 1,960 sites for AICE1 and 1,506 sites for AICE2 (data not shown).
The AICE1 motif identified from the sites with ChIP-exo binding was nearly identical to the AICE1 motif determined by de novo motif analysis via ChIP-seq ( Supplementary Fig. 8c,d) . In contrast, the A r t i c l e s AICE2 motif identified from sites with ChIP-exo binding showed enrichment for thymine at a position 4 bp upstream of the consensus binding motif for IRF relative to the frequency of thymine at this position in the AICE2 motif identified by ChIP-seq ( Fig. 6a,b) . Genes from clusters I and II showed enrichment for this thymine-containing AICE2 motif relative to its frequency in genes from cluster III, consistent with its association with high-affinity peaks (Fig. 6c,d) .
These results suggested that a thymine located at −4 bp in the AICE2 motif might increase the affinity of the binding of BATF-IRF4 to DNA and might 'tune' the sensitivity of target genes for activation by BATF-IRF4.
Identification of a high-affinity AICE consensus motif
We tested the functional effect of a thymine at −4 bp in an AICE2 by analyzing three EMSA probes derived from peaks in Ctla4 and Bcl11b that bound IRF4 by ChIP-exo analysis (Fig. 7a) . A probe derived from the low-affinity peak in the −33 kb region of Ctla4 was an AICE2 motif with cytosine at the −4 bp position in the native genome; the native probe did not form a BATF-IRF4 complex in EMSA even at high concentrations of IRF4 (Fig. 7b) . However, changing the nucleotide at −4 bp from cytosine to thymine led to the formation of a strong BATF-IRF4 complex (Fig. 7b) . Two other probes derived from highaffinity peaks in the +30 kb region of Ctla4 and the +33 kb region of Bcl11b contained thymine at the −4 bp position in the native genome ( Fig. 7a) . Both probes formed a strong BATF-IRF4 complex by EMSA ( Fig. 7b) . However, changing the thymine at −4 bp to cytosine led to loss of the complex at all concentrations of IRF4 (Fig. 7b) . These results showed that the affinity of AICE2 motifs could be 'tuned' by the DNA sequence at the −4 bp position, which lies outside the previously recognized AICE consensus motif.
Notably, an example of the high-affinity AICE2 sequence is present within a SNP in the human CTLA4 locus, in which substitution of thymine for guanine at −38 kb (rs231735) has been reported as a protective SNP for rheumatoid arthritis 26 and granulomatosis with polyangiitis 27 . Since these are T H 17 cell-related diseases 30, 31 , we analyzed CTLA-4 expression in mouse T H 17 cells and found that it was also dependent on BATF in these cells (Fig. 8a,b) . The CTLA4 SNP was located −4 bp relative to an AICE2 motif (Fig. 8c) . Conceivably, this SNP might increase the sensitivity of CTLA-4 expression to TCR stimulation by increasing the binding of BATF-IRF4. An EMSA probe based on the major guanine-containing allele of rs231735 (rs231735-G) did not form a BATF-IRF4 complex, even at high concentrations of IRF4 (Fig. 8d) . However, a probe based on the thymine-containing allele of rs231735 (rs231735-T) formed a BATF-IRF4 complex (Fig. 8d) , similar to the thymine-containing AICE2 probes above (Fig. 7b) .
We tested that SNP in a functional assay in vivo in T cells. We used a retrovirus-based reporter 32 containing the Ctla4 minimal promoter with or without insertion of an upstream 36-bp region with rs231735-G or rs231735-T (Fig. 8e) . We assessed the activity of these reporters after stable integration into T H 2 cells by activation with increasing doses of anti-CD3ε. The promoter lacking either region showed basal levels of stimulation (Fig. 8f) . Promoter activity was increased somewhat by the rs231735-G enhancer but was significantly increased further at all doses of anti-CD3ε by the rs231735-T enhancer. Notably, with the intermediate level of TCR stimulation (4.6 ng/ml of anti-CD3ε), activity was observed only with rs231735-T. These results highlighted the importance of a SNP for the binding of a transcription factor to a site and for optimal, finely tuned gene expression.
DISCUSSION
Our results have resolved a discrepancy related to the role of BATF in T H 2 cell development 24, 25 . A requirement for BATF in the development of T H 17 and T FH cells but not in the development of T H 1 or T H 2 cells has been reported in studies of Batf −/− mice in which exons 1 and 2 were deleted 21, 25 , but another study of Batf −/− mice in which exon 3 was deleted has reported an additional role for BATF in the development of T H 2 cells 24 . This discrepancy could have resulted from differences in genetic backgrounds, since the former studies used 129SvEv mice 21, 25 , while the latter study used C57BL/6 mice 24 . However, T H 2 cell development is abolished in Batf −/− mice in which Batf3 is also deleted 13 . That result shows that T H 2 development depends on activity of the BATF family and suggests that the discrepancy could have resulted from differences between the studies in the amount of compensation provided by BATF3. Here, we confirmed that interpretation by directly showing that BATF3 induced T H 2 cell development when expressed in Batf1-Batf3 DKO T cells. Furthermore, Gata3 was a BATF-dependent gene induced by low TCR signal strength and was fully induced at a level of 50% of BATF on a Batf3 −/− background, and BATF-HKE compensated for its expression. For those reasons, GATA-3 appears to be selectively compensated for by low levels of BATF3 expressed in T cells. Thus, differences in the strength of TCR stimulation and the genetic backgrounds used could have contributed to the apparent discrepancy in T H 2 cell development in Batf −/− mice 24, 25 . However, we have not addressed whether those findings also explain published claims about antigen dose and T H 1 cell-T H 2 cell balance 4, 5 or T H 1 cell-T FH cell balance 6 .
Second, our results addressed the effect of graded IRF4 expression on the activation of CD8 + T cells 9, 33 . The population expansion of CD8 + T cells requires IRF4, which is induced in a graded manner in response to different strengths of TCR signaling 9 . We found that BATF was also induced in a graded manner coordinately with IRF4. At increasing levels of BATF-IRF4 expression, we identified a hierarchy of induced genes, with genes in clusters I and II representing highly sensitive responder targets and genes in cluster III being low-sensitivity targets. We also identified (by ChIP-seq analysis) a hierarchy of IRF4-binding sites that depended on levels of BATF-IRF4 expression. Notably, global levels of IRF4 binding were different for these clusters at low levels of signaling but not at high levels of signaling, or at early times after activation. Further, the genes in cluster I and II contained more high-affinity IRF4-binding sites than did genes in cluster III. A published study has shown that histone H3 acetylated at Lys27 (H3K27ac) at BATF-binding sites 15 increases as the strength of TCR signaling is increased 34 . Our results extended that correlation by showing that the binding of IRF4 to BATF-binding sites also increased in proportion to the strength of TCR stimulation. However, we found that IRF4 binding did not increase uniformly across the genome but occurred 'preferentially' at genes with high sensitivity to BATF. In summary, we have shown that analog expression of BATF and IRF4 increasing in proportion to the strength of TCR stimulation induced a hierarchy of gene expression based on differing affinities of enhancer binding sites for the BATF-IRF4 complex.
Third, our results demonstrated how enhancers with AICE motifs were able to respond to different levels of BATF-IRF4. In essence, we found that flanking sequences surrounding a recognized AICE motif strongly influenced affinity for the BATF-IRF4 complex in a chromatin-independent manner. Varying the affinity of enhancers for transcription factors is a recognized mechanism for generating graded responses to varying strength of signaling, as, for example, in morphogen-dependent expression of target genes controlled by motifs with different affinities for Dorsal 35, 36 . Similarly, we identified enhancers with AICE1 or AICE2 motifs of identical core sequence that had variable in vivo affinity for binding BATF-IRF4, by ChIP-seq analysis. When we compared these regions by EMSA, we found that flanking sequences determined overall binding in EMSA in the same pattern as that observed in vivo by ChIP-seq. For example, Prdm1 and Ctla4 each had an AICE2 motif identified by ChIP-seq with an identical core sequence: GAAATGAGTCT. The site in Prdm1 was of high affinity, on the basis of occupancy at low TCR signal strength, while the site in Ctla4 was occupied only at high TCR signal strength. Notably, the EMSA complex formed by the AICE2 region of Prdm1 was much stronger than that formed by the region of Ctla4, despite their identical core motifs; this suggested that in vitro binding might reflect in vivo affinity. As BATF and IRF4 bind to an AICE motif that functions in T H 17 cell development 16 , the ability of flanking sequences to modulate the affinity of an AICE motif for BATF-IRF4 provides a mechanism for controlling the sensitivity of target genes to TCR signal strength. Base pairs flanking transcription-factor-binding sites are known to regulate the binding of transcription factors through DNA structure and guanine-cytosine content 37 . Dysregulation of the immune system can be observed in humans with heterozygous germline mutations of CTLA4 (ref. 38) , and the human CTLA4 SNP examined in our study is associated with protection for autoimmunity 39 . The thymine located at −4 bp in the AICE2 motif of this SNP increased in vitro binding in EMSA and increased enhancer activity in vivo, so perhaps an increase in CTLA-4 expression could act to repress autoimmunity 40 , although further work is clearly needed.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METHODS
Mice. Wild-type, Batf −/− and Batf −/− Batf3 −/− mice 22, 25 on the 129S6/SvEvTac background, DO11.10 and BALB/c mice were maintained in a specific-pathogenfree animal facility following institutional guidelines and with protocols approved by the Animal Studies Committee at Washington University in St. Louis. All experiments were performed with sex-matched mice 6-12 weeks of age without randomization or blinding.
Antibodies and flow cytometry. Cells were stained at 4 °C in the presence of Fc Block (2.4G2; BioXcell) in flow cytometry buffer (0.5% BSA in PBS). All flow cytometry antibodies were used at a dilution of 1:200. The following antibodies were used: PE-conjugated anti-CTLA-4 (UC10-4F10-11), PE-Cy7-conjugated anti-CD25 (PC81) and biotin-conjugated anti-CD8b (53-5.8) (all from Becton Dickinson (BD); Pacific blue-conjugated anti-CD4 (RM4-5), PerCP/Cy5.5-conjugated anti-Thy1.1 (OX-7), Brilliant Violet421-conjugated anti-human CD4 (OKT4), APC-conjugated anti-human CD4 (RPA-T4) and biotin-conjugated anti CD45R/B220 (RA3-6B2) (from BioLegend); APCconjugated IL-10 (JESS-16E3), efluor660-conjugated anti-GATA-3 (TWAJ), PE-conjugated anti-IRF4 (3E4) and biotin-conjugated anti-CD49b (DX5) (all from eBioscience); FITC conjugated anti-CD4 (GK1.5) (from Tonbo Biosciences); and R-PE-conjugated anti-human CD4 (S3.5) (from Invitrogen). For IL-10 and CTLA-4 staining, cells were fixed in 2% paraformaldehyde for 15 min at RT and permeabilized with 0.5% Saponin before staining. For BATF, GATA-3 and IRF4, cells were fixed and permeabilized with Foxp3 Staining Buffer Set (eBioscience) following the manufacturer's instructions. Cells were analyzed on a FACSCanto II or FACSAria Fusion and data were analyzed with FlowJo software (TreeStar).
Isolation and culture of CD4 + T cells. All cells are cultured in IMDM supplemented with 10% FCS, 2 mM glutamine, 100 IU/ml penicillin, 100 µg/ml streptomycin, 1 mM sodium pyruvate, non-essential amino acids and 55 µM β-mercaptoethanol. Spleen and lymph node cells were harvested, treated with ACK lysis buffer and passed through a 70-µm nylon filter.
For time-course and TCR-dose-titration experiments (flow cytometry, microarray and ChIP) naive CD4 + T cells were sorted as CD4 + CD25 − CD44 − cells using spleen and lymph node cells after negative selection with biotinylated antibodies to B220, DX5 and CD8 (identified above), streptavidinnanobeads and MojoSort Magnetic Cell Separation system (BioLegend). Naive CD4 + T cells were activated with soluble anti-CD3ε (145-2C11, BioXCell) at 1, 2.2, 4.6, 10, 22 and 46 ng/ml cross-linked by plate-bound anti-hamster IgG (MP biomedicals cat.# 55397 1:50) and anti-CD28 (37.51, BioXCell) (4 µg/ml) under T H 2 conditions (anti-IFN-γ 10 µg/ml (XMG1.2, BioXCell), anti-IL-12 10 µg/ml (Tosh; prepared in-house), IL-4 10 ng/ml (Peprotech)) and were analyzed on at various times after primary activation as indicated in the figure legends.
For peptide-dose titration, naive KJ126 + cells from DO11.10 mice were purified and activated with MACS-purified CD11c + dendritic cells from spleens of BALB/c mice in the presence of ovalbumin peptide (amino acids 323-339) under T H 2 conditions. Cell populations were expanded threefold on day 3 and were analyzed by flow cytometry on day 4.
For experiments using secondary stimulations, CD4 + T cells were isolated using Dynabeads FlowComp Mouse CD4 kit (Invitrogen) and were activated on plates coated with anti-CD3ε (500A2 ascites diluted 1:400 to achieve maximal activation) and anti-CD28 (37.51, 4 µg/ml, BioXCell) under T H 2 conditions. On day 3, cells were diluted threefold in fresh media on uncoated plates. On day 7, cells were re-stimulated under the same conditions or were re-stimulated using soluble anti-CD3ε (145-2C11, 1 µg/ml, BioXCell) at various concentrations cross linked by plate-bound anti-hamster IgG (MP biomedicals, cat.# 55397 1:50) and anti-CD28 (37.51, BioXCell) (4 µg/ml) under T H 2 conditions. On day 4 of the second stimulation, cells were analyzed by flow cytometry for expression of GATA-3 and CTLA-4, or were activated by PMA and ionomycin in the presence of brefeldin A for 5 h for analysis of IL-10 expression, or for 2 h for ChIP.
EMSA.
Oligonucleotide pairs were annealed to generate probes that were labeled with 32 P-dCTP using Klenow polymerase ( Supplementary Table  2 ). HEK293FT cells were transiently transfected with retroviral vectors for Batf, JunB or Irf4 using TransIT-LT1. After 48 h, cells were lysed with buffer A (10 mM HEPES-KOH, pH 7.9, 1.5 mM MgCl 2 and 10 mM KCl) containing 0.2% NP40 and protease inhibitors. Nuclei were pelleted, resuspended in buffer C (20 mM HEPES-KOH, pH 7.9, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA and 25% glycerol), and centrifuged to obtain nuclear extracts 41 . EMSA was essentially as described 42 using combinations of nuclear extracts from cells transfected with Batf, JunB and Irf4 (up to 1.5 µg total), 0.25 µg poly dI-dC (Sigma) and 32 P-labeled probes in 10 µl binding reactions for 20 min at 4 °C. Reactions were separated on 4-7%T 3.3%C polyacrylamide mini-gels in 0.4× TBE for 50 min at 250 V and 4 °C and were analyzed by autoradiography.
Retroviral analysis. Retroviral vectors were transfected into Plat-E cells with
TransIT-LT1 (Mirus Bio) and viral supernatants were collected 2 d later. On day 1 after activation of CD4 + T cells, culture medium was replaced with supernatants of transfected packaging cells containing 6 µg/ml polybrene. Cells were transduced by centrifugation at room temperature for 90 min at 1,170g. Viral supernatant was replaced by T H 2 culture medium.
Enhancer elements were cloned into a retroviral reporter with additional insertion of polyA sequence upstream of enhancer sites (hCD4 pA GFP RV) 32 ( Supplementary Table 3 ). For analysis, we used integrated MFI, which combines the metrics of frequency and MFI as a measure of total functional response 43, 44 .
For ChIP-seq analysis of retrovirally transduced cells, infected cells were sorted on day 6 after primary activation, re-stimulated on day 7 and harvested on day 11 following PMA-ionomycin activation for 2 h.
Expression microarray analysis. Total RNA was extracted using RNAqueous-Micro Kit (Ambion) and was amplified with the Ovation Pico wild-typeA Sytem (NuGEN) and hybridized to GeneChip Mouse Gene 1.0 ST microarrays (Affymetrix). Data were normalized by robust multiarray average summarization and quartile normalization with ArrayStar software (DNASTAR). The log 2 -transformed data were imported into the software of the R project (version 3.2.3). Differential expression analyses were performed using limma package of R and P-value were corrected by the Benjamini-Hochberg procedure 45 . Spearman's rank correlation coefficient plot was generated by R. Hierarchical clustering was performed with Euclidean distance and Ward clustering using of R.
ChIP-seq. ChIP was performed as described 32 with minor modifications. In brief, 1 × 10 7 activated CD4 + T cells were collected, crosslinked with 1% formaldehyde at room temperature for 8 min, quenched with 1.25 M glycine and washed twice with PBS. Pellets were 'flash frozen' for storage at −80 °C. Chromatin was sonicated for 24 cycles of 20 s on and 50 s off per cycle with a Vivra-Cell VCX130PB and CV188 sonicators (Sonics & Material) in lysis buffer (10 mM Tris pH?, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% sodium deoxycholate, 0.5% N-lauroylsarcosine). Chromatin was immunoprecipitated overnight at 4 °C with Dynabeads Protein A or G (Invitrogen) that had been pre-incubated with 5 µg of antibody: anti-IRF4 (sc-6059X; Santa Cruz Biotechnology), rabbit anti-BATF (prepared in-house) 25 , or rabbit anti-BATF3 (prepared in-house) 13 . Beads containing protein-DNA complexes were washed two times with RIPA buffer (10 mM Tris, pH 7.5, 140 mM NaCl, 1 mM EDTA, 0.1% SDS, 0.1% sodium deoxycholate and 1% Triton-X), two times with RIPA buffer plus 0.3 M NaCl, two times with LiCl buffer (0.21 M LiCl, 0.5% NP-40 and 0.5% sodium deoxycholate), two times with Tris-EDTA-Triton-X buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 0.2% Triton-X), and twice with Tris-EDTA. DNA fragments were eluted and reverse-crosslinked by incubation for 5 h at 65 °C in Tris-EDTA, pH 8.0, with 0.3% SDS, 1 mg/ml Proteinase K (New England BioLabs). DNA was purified by phenol-chloroform extraction followed by ethanol precipitation. Libraries for ChIP-seq were prepared from 1 ng of ChIPed DNA with a ThruPLEX-FD kit (Rubicon Genomics) and were sequenced with an Illumina HiSeq 2500 as single 'reads' extending 50 bases.
Computational analysis for ChIP-seq. ChIP-seq data sets were aligned to the mouse genome (NCBI37/mm9 assembly) by Bowtie software (version 1.1.1) 46 with the following parameters:-sam-best -p4 -m 1-chunkmbs 8000. Uniquely mapped reads were masked with Samtools 47 with blacklist of the ENCODE project 48 and the RepeatMasker program (which screens for interspersed repeats and low complexity) in the UCSC Genome Browser. Duplicated reads are discarded using 'make tag directory' of Homer software package 49 with the parameter -tbp 1. Data were visualized with the 'makeUCSCfile' of Homer. Peaks from individual conditions were identified with 'findPeaks' of Homer with a 300 bp window and Poisson P value of <1 × 10 −10 and with normalized tag counts fourfold more than control (input sample). IRF4 peaks from individual of ChIP-seq experiments at primary stimulation conditions (10 ng/ml and 2 ng/ml on day 4 and 10 ng/ml on day 2) were merged using 'mergePeaks' of Homer and were centered and trimmed to 300 bp. Tag counts per peak were calculated with 'annotatePeaks.pl' of Homer. Spearman's rank correlation coefficient of tag counts on merged IRF4 peaks between each ChIP-seq experiment were performed by R. Peak related indicated genes were extracted from merged IRF4 peaks within transcription start site ± 50 kb using 'intersectBed' of BedTools package 50 . High-affinity peaks were defined as merged IRF4 peaks with tag counts with more than a threshold of Poisson P value of 1 × 10 −10 in all three experiments (10 ng/ml and 2 ng/ml on day 4 and 10 ng/ml on day 2). Intermediate-affinity peaks were defined as merged IRF4 peaks with tag counts more than threshold in two of three experiments, and low-affinity peaks have tag counts more than threshold in one of three experiments. The heat map of binding intensity was generated using 'annotatePeaks.pl' of Homer and R. De novo motif analysis was performed from the top 3,000 peaks, which were ranked by sum of tag counts per peak of the three experiments (10 ng/ml and 2 ng/ml on day 4 and 10 ng/ml on day 2), using 'findMotifsGenome.pl' of Homer with 150 bp window. Putative motif loci of motifs from each category (high-affinity, intermediate-affinity and low-affinity) were extracted from merged IRF4 peaks with de novo motifs using 'annotatePeaks.pl' , length of motifs were adjusted and motifs were merged to one bed file using 'intersect-Bed' . Motif logos were generated by the 'seqLogo' package of R.
ChIP-exo analysis. ChIP-exo analysis was performed as described 51 with minor modifications. In brief, 'ChIPed' DNA-antibody-bead complexes from 30 × 10 6 cells per experiment were washed with RIPA buffer six times, and Tris-EDTA, pH 8.0, twice. The ChIP-exo libraries were made by the following enzymatic reactions with four washes between each reaction; End polishing by T4 DNA polymerase, Klenow DNA polymerase, T4 polynucleotide kinase, ligation of P7 exo-adaptor by T4 DNA ligase, nick repair by Phi29 DNA polymerase, exonuclease reaction by lambda exonuclease and cleaning-up single strand DNA by RecJf exonuclease. DNA was eluted and reversecrosslinked as above. The libraries were generated by P7 primer extension with Phi29 DNA polymerase, ligation of P5 exo-adaptor with T4 DNA ligase, PCR amplification with Phusion polymerase for 12 cycles and were cleaned up by AMPure XP.
Computational analysis of ChIP-exo analysis. ChIP-exo data sets were aligned and masked as above. We kept duplicated tags and shrunk 50 bp of reads to first 1 bp of 5′ position for further analysis. For visualizing, four replicates of BATF and two replicates of IRF4 were combined and normalized to 10 million tags. Bedgraphs were generated by 'genomeCoverageBed' of BedTools. ChIP-exo tag counts per base of motif ± 50 bp were measured by ' coverageBed' of BedTools and were visualized by R after normalization to 10 million tags per experiments. We chose putative narrow exonuclease stopped position (exo binding region) around motifs and non-binding region (control region) based on the mean ChIP-exo tag counts around consensus motifs and motifs predicted by ChIP-seq ( Fig. 5d and Supplementary Fig. 6a ). We applied 20 bp of exo-binding region and control regions for BATF and 10 bp for IRF4. We defined the motif sites with BATF and IRF4 ChIP-exo binding that satisfied the following criteria: threshold, total tag counts on target region of four experiments for BATF or two experiments for IRF4 were more than the threshold (Poisson P value of 1 × 10 −6 ); significance of exo binding region versus control region, differential analysis between log 2 -transformed ChIP-exo tag counts on exo-binding region (eight regions for BATF; four regions for IRF4) and ChIP-exo tag counts on control regions (16 regions for BATF; 8 regions for IRF4) in each experiment were performed by Welch's t-test with Storey's correction 52 (P < 0.05); and change in binding, the mean of tag counts on exo-binding region was more than twofold higher than the mean of tag counts on control region. Motif logos were generated by the 'seqLogo' package of R.
Statistical analysis. All statistical analyses were performed using Prism (GraphPad Software) or R.
Data availability. Data have been deposited in the GEO database: microarray data, GSE85173; ChIP-seq and ChIP-exo data, GSE85172.
